| Autor: |
Cassyano Januário Correr, Wendel Coura-Vital, Josélia Cintya Quintao Pena Frade, Renata Cristina Rezende Macedo do Nascimento, Lúbia Guaima Nascimento, Eliete Bachrany Pinheiro, Wesley Magno Ferreira, Janice Sepúlveda Reis, Karla Fabiana Santana de Melo, Roberto Pontarolo, Mônica Soares Amaral Lenzi, José Vanilton de Almeida, Hermelinda Cordeiro Pedrosa, Walter da Silva Jorge João |
| Rok vydání: |
2020 |
| Popis: |
Background Brazil is one of top 10 countries with the highest number of people with diabetes mellitus (DM), affecting 16.8 million peoples. It is estimated that 7.7 million people (20–79 years) in the country have not yet been diagnosed, representing an under-diagnosis rate of 46%. Herein we aimed to screen people for high blood glucose or risk for developing type 2 DM (T2DM) through community pharmacies in Brazil. Methods A cross-sectional study was carried out in November 2018, involving 977 pharmacists from 345 municipalities in Brazil. The study evaluated people between 20 and 79 years old without a previous diagnosis of DM. Glycemia was considered high when its value was ≥ 100 mg/dL fasting and ≥ 140 mg/dL in a casual feeding state. The FINDRISC (Finnish Diabetes Risk Score) was used to estimate the risk for developing T2DM. The prevalence of high blood glucose was estimated and the associated factors were obtained using Poisson's multivariate analysis with robust variance. Results During the national screening campaign, 17,580 people were tested with the majority of the consultations (78.2%) being carried out in private pharmacies. The population was composed mainly of women (59.5%) and people aged between 20 and 45 years (47.9%). The prevalence of patients with high blood glucose was 18.4% (95% CI 17.9–19.0). Considering the FINDRISC, 22.7% of people had a high or very high risk for DM. The risk factors associated with high blood glucose were: Body Mass Index > 25 kg/m2, abdominal circumference > 94 cm for men and > 80 cm for women; education level below 15 years of study, no daily intake of vegetables and fruits; previous diagnosis of arterial hypertension; history of high blood glucose and family history of DM. Conclusions This is the largest screening study that evaluated the prevalence of high blood glucose and its associated factors in a population without a previous diagnosis, ever performed in community pharmacies in Brazil. These results may help to guide public health preventive actions and involve pharmacists in screening and education actions aimed at this undiagnosed population in a continent-size country such as Brazil. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
